Progress on standardized treatment for patients with general cancer pain and cancer pain during " peri-radiotherapeutic period"

中华放射肿瘤学杂志 Pub Date : 2020-01-15 DOI:10.3760/CMA.J.ISSN.1004-4221.2020.01.017

B. Tan

{"title":"Progress on standardized treatment for patients with general cancer pain and cancer pain during \" peri-radiotherapeutic period\"","authors":"B. Tan","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.01.017","DOIUrl":null,"url":null,"abstract":"Cancer pain is one of the main symptoms of patients suffering from malignant tumors. If it is not timely treated, it will lead to refractory pain and increase the burden on both the individuals and society. In China, the program titled\" Good Pain Management\" has been carried out for nearly 7 years, which increases the overall assessment and treatment levels for cancer pain among medical personnel. Nevertheless, the clinical efficacy for cancer pain treatment is not satisfactory. As an important treatment for malignant tumors, radiation therapy is also one of the main methods for treating cancer pain. For the first time, we proposed the concept of \" peri-radiotherapeutic period\" , and emphasized the continuous analgesic treatment for patients with cancer pain before, during and after radiotherapy. In this article, current status of cancer pain treatment at home and abroad was illustrated, and standardized assessment and management of cancer pain during the \" peri-radiotherapeutic period\" were summarized. \n \n \nKey words: \nCancer pain; Neoplasm/radiotherapy; Peri-radiotherapeutic period; Opioid drug","PeriodicalId":10288,"journal":{"name":"中华放射肿瘤学杂志","volume":"29 1","pages":"73-78"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华放射肿瘤学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.01.017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Cancer pain is one of the main symptoms of patients suffering from malignant tumors. If it is not timely treated, it will lead to refractory pain and increase the burden on both the individuals and society. In China, the program titled" Good Pain Management" has been carried out for nearly 7 years, which increases the overall assessment and treatment levels for cancer pain among medical personnel. Nevertheless, the clinical efficacy for cancer pain treatment is not satisfactory. As an important treatment for malignant tumors, radiation therapy is also one of the main methods for treating cancer pain. For the first time, we proposed the concept of " peri-radiotherapeutic period" , and emphasized the continuous analgesic treatment for patients with cancer pain before, during and after radiotherapy. In this article, current status of cancer pain treatment at home and abroad was illustrated, and standardized assessment and management of cancer pain during the " peri-radiotherapeutic period" were summarized. Key words: Cancer pain; Neoplasm/radiotherapy; Peri-radiotherapeutic period; Opioid drug

查看原文本刊更多论文

一般性癌性疼痛及“围放疗期”癌性疼痛的规范化治疗进展

癌症疼痛是恶性肿瘤患者的主要症状之一。如果不及时治疗，将导致顽固性疼痛，并增加个人和社会的负担。在中国，名为“良好疼痛管理”的项目已经开展了近7年，这提高了医务人员对癌症疼痛的总体评估和治疗水平。然而，癌症疼痛治疗的临床疗效并不令人满意。放射治疗作为恶性肿瘤的重要治疗手段，也是治疗癌症疼痛的主要方法之一。我们首次提出了“放疗周”的概念，强调对癌症疼痛患者在放疗前、放疗中、放疗后的持续镇痛治疗。本文介绍了国内外癌症疼痛治疗的现状，总结了癌症疼痛“围治期”的规范化评估和管理。关键词：癌症疼痛；肿瘤/放疗；围放疗期；阿片类药物

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

中华放射肿瘤学杂志

自引率

0.00%

发文量

6375

期刊介绍： The Chinese Journal of Radiation Oncology is a national academic journal sponsored by the Chinese Medical Association. It was founded in 1992 and the title was written by Chen Minzhang, the former Minister of Health. Its predecessor was the Chinese Journal of Radiation Oncology, which was founded in 1987. The journal is an authoritative journal in the field of radiation oncology in my country. It focuses on clinical tumor radiotherapy, tumor radiation physics, tumor radiation biology, and thermal therapy. Its main readers are middle and senior clinical doctors and scientific researchers. It is now a monthly journal with a large 16-page format and 80 pages of text. For many years, it has adhered to the principle of combining theory with practice and combining improvement with popularization. It now has columns such as monographs, head and neck tumors (monographs), chest tumors (monographs), abdominal tumors (monographs), physics, technology, biology (monographs), reviews, and investigations and research.